Up next in 10
#science #mentalhealth #chemistry #medical #scientificinsights #discoveries #psychology #brainscience #ai #technology #pharmaceutical #study #trials #depression #antidepressants
#Rejoyn #RejoynApp #RejoynReview
Show More Show Less View Video Transcript
0:00
[Music]
0:01
welcome to CIS
0:04
Corner imagine being able to manage
0:07
depression right from your smartphone
0:09
sounds futuristic right well the FDA has
0:13
just approved a digital therapeutic app
0:16
rejoin for the treatment of major
0:18
depressive disorder let's get into how
0:21
this revolutionary app works and what it
0:23
means for the future of Mental Health
0:25
Care rejoin developed by OA
0:28
pharmaceutical and click Therapeutics
0:31
has recently received FDA clearance this
0:34
app is designed as an adjunctive
0:36
treatment for adults with major
0:38
depressive disorder MDD who are already
0:41
on anti-depressant medication unlike
0:44
regular Wellness apps rejoin is a
0:47
medical device that requires a
0:48
prescription and offers clinically
0:51
validated cognitive emotional training
0:53
exercises the app's six- we program
0:56
focuses on enhancing cognitive control
0:58
of emotions through interactive
1:00
exercises and brief therapeutic lessons
1:04
in clinical trials users of rejoin
1:06
showed significant Improvement in
1:08
depression symptoms with results
1:10
consistent across various psychological
1:13
scales what makes rejin Stand Out is its
1:16
neuromodulatory mechanism akin to
1:19
physical therapy for the brain aiming to
1:21
improve neural connections and emotional
1:25
regulation this Innovative approach
1:27
targets the brain's neuroplasticity
1:29
helping to alleviate depression symptoms
1:32
by strengthening the neural Pathways
1:34
involved in Emotion processing and
1:36
cognition the marai study a pivotal
1:39
trial involving
1:41
386 participants demonstrated rejoins
1:45
efficacy without any treatment related
1:47
Adverse Events participants who used
1:50
rejoin continued to show Improvement
1:52
even a month after the treatment ended
1:55
this app represents a new horizon in
1:57
digital Therapeutics offering hope and a
2:00
new tool for those struggling with
2:02
depression but despite its promising
2:05
results experts warn that it may carry
2:07
some risks and that the app should not
2:09
be used as an alternative for
2:12
anti-depressants Dr John torus who was
2:14
involved in the app project said if the
2:17
benefit is minimal but the risks are
2:19
minimal perhaps there's no harm in
2:21
trying it he said hopefully we see more
2:25
evidence come out in the future because
2:27
as a clinician psychiatrist I want to
2:30
make sure people use something that is
2:31
going to make them better if you or
2:34
someone you know is battling depression
2:36
rejoin might be the key thanks for
2:39
watching and stay tuned for more updates
2:41
on the latest scientific discoveries
#Mental Health
#Depression